Pharmalittle: We're reading about FDA view on peptide compounding, Iran war hurting trial recruitment, and more
The FDA is moving toward allowing compounding pharmacies to produce injectable peptides that were banned over significant safety concerns
N
NewsHub
Apr 02, 2026
1 min read
The FDA is moving toward allowing compounding pharmacies to produce injectable peptides that were banned over significant safety concerns
Tags:
top
Source url: https://www.statnews.com/pharmalot/2026/04/01/fda-compounding-peptides-iran-war-trial-recruitment/
Related Articles
